Compare DK & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DK | RLAY |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2006 | 2020 |
| Metric | DK | RLAY |
|---|---|---|
| Price | $30.57 | $7.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $35.53 | $16.00 |
| AVG Volume (30 Days) | 1.3M | ★ 2.3M |
| Earning Date | 02-24-2026 | 02-25-2026 |
| Dividend Yield | ★ 3.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,667,200,000.00 | $8,355,000.00 |
| Revenue This Year | N/A | $20.47 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.03 | $1.78 |
| 52 Week High | $43.50 | $9.04 |
| Indicator | DK | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 37.13 | 50.52 |
| Support Level | $28.59 | $7.85 |
| Resistance Level | $30.91 | $8.66 |
| Average True Range (ATR) | 1.23 | 0.42 |
| MACD | 0.21 | -0.10 |
| Stochastic Oscillator | 50.82 | 30.43 |
Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).